Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $461.55 | Total: $2,307.75 |
| 1 | 10 | $390.96 | Total: $3,909.60 |
| 1 | 25 | $331.23 | Total: $8,280.75 |
| 1 | 50 | $282.36 | Total: $14,118.00 |
| 1 | 100 | $244.35 | Total: $24,435.01 |
Overview
Ragaglitazar(NNC-61-0029) is a potent dual PPAR? and PPAR? agonist that has shown potent lipid-lowering and insulin sensitizing effects in animal models.Ragaglitazar can be used to study type 2 diabetes.
Chemical Properties
| Molecular Formula | C25H25NO5 |
| Molecular Weight | 419.47 |
| CAS Numbers | 222834-30-2 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | C(COC1=CC=C(C[C@H](OCC)C(O)=O)C=C1)N2C=3C(OC=4C2=CC=CC4)=CC=CC3 |
Storage and Handling
0C Short Term, -20C Long Term
References
Saad MF, Greco S, Osei K, et al. Ragaglitazar improves glycemic control and lipid profile in type 2 diabetic subjects a 12-week, double-blind, placebo-controlled dose-ranging study with an open pioglitazone arm. Diabetes Care. 2004;27[6] 1324-1329.